GlassScriptPhysician profile
Sangeeta Sinha
NPI 1972591600
$4,453.70
in general payments reported to CMS, 2019-2025
26 companies · $501 in 2025
The $501 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2020: $94.93 · 2021: $139 · 2022: $581 · 2023: $488 · 2024: $670 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,858.39 | 2019 | |
| Abbvie INC. | $350.73 | 2019-2024 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $233.64 | 2019-2025 | Paragard T 380a, Ally II Ups, Mara Console |
| Organon LLC | $214.45 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $173.05 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $169.84 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $161.35 | 2019-2025 | |
| Myovant Sciences INC. | $147.95 | 2022 | |
| Sumitomo Pharma America, INC. | $136.86 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $134.60 | 2022-2025 | Zurzuvae |
| Ethicon US, LLC | $127.41 | 2023-2025 | Enseal, Surgicel Nu-Knit, Vistaseal |
| Novo Nordisk INC | $97.48 | 2025 | Wegovy |
| Exact Sciences Corporation | $77.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $74.05 | 2024-2025 | |
| Optumhealth Care Solutions, LLC | $67.47 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $66.58 | 2022-2023 | Ova1 |
| Merck Sharp & Dohme LLC | $63.69 | 2019-2020 | |
| Avion Pharmaceuticals | $48.59 | 2020-2022 | |
| Innovation Technologies INC | $45.44 | 2023 | Irrisept |
| Medtronic, INC. | $43.35 | 2024 | Ligasure |
| Pfizer INC. | $40.90 | 2024 | |
| Hologic Sales and Service, LLC | $34.43 | 2025 | Aptima |
| Becton, Dickinson and Company | $28.65 | 2024 | Bd Max System, Bd Max Instrument |
| Exeltis, USA INC. | $22.02 | 2022 | |
| Amag Pharmaceuticals, INC. | $19.37 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.74 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sangeeta Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.